✦ LIBER ✦

A phase II activity and safety study of oral doxifluridine (5′-dFUR) in elderly patients with advanced non small cell lung cancer (NSCLC)

✍ Scribed by Conte, P.F.; Baldini, E.; Pfanner, E.; Ricci, S.; Falcone, A.; Ceribelli, A.; Sarcina, R.; Comella, G.; Gallo Stampino, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral etoposide preceding cisplatin in ad

✍ Focan, C.; Vandermoten, G.; Boossy, J.; Schallier, D. 📂 Article 📅 1988 🏛 Elsevier Science ⚖ 571 KB

34 Phase II study of LY231514 in patient

✍ Clarke, S.; Boyer, M.; Millward, M.; Findlay, M.; Ackland, S.; Childs, A.; Brew, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Single agent Gemcitabine for elderly pat

✍ Burkes, R.L; Wilson, J; Shepherd, F.A; Spadafora, S; Iglesias, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 111 KB

A phase II study of low dose vinorelbine

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Results of a phase II study with vinorel

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Gemcitabine monotherapy in elderly patie

✍ Ricci, S 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 80 KB